Teladoc Health (TDOC) Cost of Revenue (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Cost of Revenue data on file, last reported at $197.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 305.66% year-over-year to $197.5 million; the trailing twelve-month figure through Mar 2026 stood at $482.3 million (down 45.39% YoY), and the FY2025 full-year result was $194.5 million, down 74.11% from the prior year.
• Cost of Revenue advanced to $197.5 million in Q1 2026, from $47.7 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $599.0 million in Q4 2024 to a low of -$352.8 million in Q4 2023.
• A 5-year average of $125.5 million and a median of $186.0 million in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue plunged 286.81% in 2023 and soared 305.66% in 2026, its largest moves.
• Tracing TDOC's Cost of Revenue over 5 years: stood at $188.9 million in 2022, then sank by 286.81% to -$352.8 million in 2023, then soared by 269.77% to $599.0 million in 2024, then tumbled by 92.04% to $47.7 million in 2025, then surged by 314.4% to $197.5 million in 2026.
• Business Quant data shows TDOC's Cost of Revenue at $197.5 million in Q1 2026, $47.7 million in Q4 2025, and $187.2 million in Q3 2025.